Implantable cardiac rhythm management device market to reach $24.91 billion by 2030

The implantable cardiac rhythm management device market is projected to grow from $17.7 billion in 2025 to $24.91 billion by 2030, fueled by rising cardiac disease, an aging population and wider use of smart, remotely monitored devices. North America held the largest market share in 2025 as demand tracks higher rates of arrhythmia and broader cardiac care access.

Why it matters: - Demand for implantable cardiac rhythm management devices is rising as heart disease, arrhythmias and age-related cardiac conditions become more common. - The market’s growth signals more use of devices that can help regulate heart rhythm, support remote monitoring and reduce invasive care needs. - The market’s expansion also reflects broader investment in cardiac care infrastructure and digital health tools.

What happened: - The Business Research Company said the implantable cardiac rhythm management device market grew from $17.7 billion in 2025 to a projected $18.89 billion in 2026. - The market is forecast to reach $24.91 billion by 2030, based on a 7.2% compound annual growth rate. - North America held the largest share of the market in 2025. - The report covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A sample report is available here. - The full report is available here.

The details: - Implantable cardiac rhythm management devices are compact, battery-powered devices placed inside the body and connected to the heart. - The devices are used to maintain and regulate heart rhythm in patients with arrhythmias or other heart function abnormalities. - Growth in the historic period was linked to rising prevalence of cardiac arrhythmias, an aging population, expansion of cardiac care centers, wider use of implantable pacemakers and defibrillators, and better device durability and reliability. - The report identifies smart implantable devices, remote patient monitoring, AI-powered rhythm analysis, minimally invasive cardiac procedures and investment in cardiac healthcare infrastructure as key growth drivers through 2030. - The report also highlights remote monitoring, advanced battery technology, wireless connectivity, less invasive implantation techniques and longer device life as key trends. - The devices can help patients with heart failure and reduced left ventricular function by resynchronizing heart contractions and restoring normal rhythm during dangerous ventricular arrhythmias. - American Heart Association data cited in the report showed the US age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, up 4% from the previous year. - Population Reference Bureau data cited in the report showed the US population aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050. - That age group’s share of the US population is projected to increase from 17% to 23% over the same period.

Between the lines: - The forecast points to a market shaped by both medical need and technology upgrades. - Remote monitoring and AI analysis suggest the category is moving toward more connected, data-driven care. - North America’s lead likely reflects stronger healthcare infrastructure and faster adoption of advanced devices.

What's next: - The market is expected to keep expanding as smart implantable devices and minimally invasive procedures become more widely adopted. - Device makers are likely to focus on battery life, wireless connectivity and performance improvements. - The report says updated 2026 materials now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, hotspot infographics, and updated graphics and tables. - The Business Research Company listed Saumya Sahay as a contact for expert inquiries, with regional phone numbers and marketing@tbrc.info.

The bottom line: - The implantable cardiac rhythm management device market is on a steady growth path, driven by rising heart disease, an older population and more advanced connected devices.